Core Viewpoint - Several companies are planning to reduce their shareholdings, indicating potential shifts in ownership and investor sentiment in the market [1] Shareholder Reductions - Senba Sensor's actual controller's concerted action party plans to reduce holdings by no more than 1.09% [1] - Erkang Pharmaceutical's controlling shareholder intends to reduce holdings by no more than 2.04% [1] - Andeli's shareholder BVI Donghua plans to reduce holdings by no more than 1.00% [1] - Zhiyang Innovation's controlling shareholder and its concerted action party plan to reduce a total of no more than 4.225 million shares [1] - Sichuan Gold's shareholder Beijing Jinyang intends to reduce holdings by no more than 1.8% [1] - Guoji Heavy Industry's shareholders, including Bank of China Deyang Branch and Bank of China Zhenjiang Runzhou Branch, plan to reduce a total of no more than 1% [1] - Meixin Sheng's shareholder WI Harper Fund VII plans to reduce holdings by no more than 1% [1] - Yanmian Technology's actual controller and controlling shareholder Liu Yan plan to reduce a total of 1.2897% of the company's shares [1] - Jingwei Henghai's supervisor Cui Wenge plans to reduce no more than 600,000 shares [1] - New Xiangwei's shareholder Kehongxin plans to reduce holdings by no more than 1% [1] - Wujin Stainless Steel's three executives plan to reduce a total of no more than 623,400 shares [1] - Zhongrun Optical's director Lu Gaofei plans to reduce no more than 695,300 shares [1] Regulatory Actions - *ST Mubang's actual controller Liao Zhiyuan has received a notice of investigation from the China Securities Regulatory Commission [1] - Youkeshu's shareholder has also received a notice of investigation from the China Securities Regulatory Commission [1]

Group 1 - Yinglian Co., Ltd. expects a net profit of 34.5 million to 37.5 million yuan for the first three quarters of 2025, representing a year-on-year increase of 1531% to 1673% [1] - China CNR Corporation signed major contracts totaling approximately 54.34 billion yuan, accounting for 22% of its expected revenue for 2024 [1] - Shengmei Shanghai reported a total order amount of 9.072 billion yuan, a year-on-year increase of 34.1% [2] Group 2 - Fulian Precision plans to increase capital in its subsidiary Jiangxi Shenghua with a total investment of 35.63 billion yuan, which is expected to constitute a major asset restructuring [3] - Aimeike has obtained a drug registration certificate for Minoxidil topical solution, which is used for treating male pattern baldness [4] - Guolin Technology is planning to acquire 91.07% of Kailianjie’s equity for cash, which is expected to constitute a major asset restructuring [5] Group 3 - Baicheng Co. plans to purchase 55% of Shanghai Canxi Engineering Equipment Co. and will suspend trading of its stock starting September 30, 2025 [6][7] - Diaowei is planning to acquire equity in Rongpai Semiconductor and has suspended trading of its stock [8] - Xiatun New Energy signed a strategic cooperation framework agreement with Zhongwei Co. to establish a long-term partnership in the supply chain for solid-state lithium battery materials [9] Group 4 - Lingyi Zhi Manufacturing is planning to issue H-shares and list on the Hong Kong Stock Exchange to enhance its international strategy [10] - Baicheng Pharmaceutical received clinical trial approval for its innovative drug BIOS-0623-Z4, which targets cancer pain treatment [11] - Weide Information announced a preliminary transfer price of 40.33 yuan per share, representing a 26% discount to its closing price [12] Group 5 - Huayou Cobalt's subsidiary signed contracts with LGES for the supply of 76,000 tons of ternary precursor materials and 88,000 tons of ternary cathode materials from 2026 to 2030 [13] - Hubei Energy signed a cooperation agreement with the Xiangyang Municipal Government to invest 26.7 billion yuan in clean energy projects [14]

Group 1 - Yinglian Co., Ltd. expects a net profit increase of 1531.13% to 1672.97% year-on-year for the first three quarters of 2025, with projected revenue of 1.63 billion to 1.65 billion yuan, a growth of 9.49% to 10.83% [1] - Meixin Sheng plans to reduce its shareholding by no more than 1% through centralized bidding and block trading [1] - Huayin Technology signed two sales contracts totaling 402 million yuan, with one contract for special functional materials and another for research project materials [3] Group 2 - Shen Highways reported a total toll revenue of 114 million yuan for August [5] - Dash Smart signed a contract worth 113 million yuan for a smart hospital project [7] - Tianbang Food received an administrative regulatory measure decision from the China Securities Regulatory Commission for failing to disclose information in a timely manner [8] Group 3 - Fashilong plans to invest 250 million yuan to establish a wholly-owned subsidiary focused on AI applications and cloud computing [10] - Junpu Intelligent received a government subsidy of 20 million yuan, accounting for 243.97% of its audited net profit for 2024 [11] - Longyun Co. plans to apply for a bank credit limit of 32 million yuan [12] Group 4 - Yifan Pharmaceutical's subsidiary received acceptance for a drug registration application for a medication used to lower phenylalanine levels in patients [12] - Rundu Co. received a drug registration certificate for a hypertension medication [13] - Huahai Qingke elected a new employee director and appointed a new vice president [17] Group 5 - Wanyi Technology received a government subsidy of 173,000 yuan [19] - Haizheng Pharmaceutical's tacrolimus capsules passed the consistency evaluation for generic drugs [20] - Pulaike's new veterinary vaccine received registration certification [22] Group 6 - Boguang New Materials signed a major sales contract estimated at 4.3 billion to 5 billion yuan for nickel powder products [41] - Electric Soul Network announced plans for shareholders to reduce their holdings by up to 1.63% [42] - Jin Haitong's shareholders plan to reduce their holdings by up to 3% [44]

美芯晟(688458.SH)发布公告，因自身需要，股东WI Harper Fund VII拟通过集中竞价、大宗交易方式减 持公司股份不超过111.54万股，即不超过公司总股本的1%，减持期限为自公告披露之日起15个交易日 后的3个月内进行。 ...

智通财经APP讯，美芯晟(688458.SH)发布公告，因自身需要，股东 WI Harper Fund VII 拟通过集中竞 价、大宗交易方式减持公司股份不超过111.54万股，即不超过公司总股本的1%，减持期限为自公告披 露之日起15个交易日后的3个月内进行。 ...

Core Viewpoint - The major shareholder WI HARPER FUND VII HONG KONG LIMITED plans to reduce its stake in the company by up to 1% of the total share capital between October 29, 2025, and January 28, 2026, citing personal needs as the reason for the reduction [1] Summary by Relevant Sections - Shareholder Action - WI HARPER FUND VII HONG KONG LIMITED intends to sell up to 1.1154 million shares, which represents no more than 1% of the company's total share capital [1] - The reduction will occur through centralized bidding and block trading methods [1] - Timing and Pricing - The planned reduction period is from October 29, 2025, to January 28, 2026 [1] - The selling price will be determined based on market conditions at the time of the sale [1]

南财智讯9月29日电，美芯晟公告，公司股东WIHARPERFUNDVIIHONGKONGLIMITED计划在2025年 10月29日至2026年1月28日期间，通过集中竞价和大宗交易方式减持公司股份不超过111.5366万股，占 公司总股本的比例不超过1%。减持原因为自身需要。减持价格按市场价格确定。 WIHARPERFUNDVIIHONGKONGLIMITED目前持有公司股份624.0029万股，占公司总股本的5.59%。 ...

证券代码：688458 证券简称：美芯晟 公告编号：2025-050 美芯晟科技（北京）股份有限公司 股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 大股东持有的基本情况 2 董事、监事和高级管理人员 □是 √否 其他：/ 持股数量 6,240,029股 持股比例 5.59% 当前持股股份来源 其他方式取得：6,240,029股(IPO 前及上市后资本公积 转增股本取得） 上述减持主体无一致行动人。 截至本公告披露日，美芯晟科技（北京）股份有限公司（以下简称"公司"） 股东 WI HARPER FUND VII HONG KONG LIMITED（以下简称"WI Harper Fund VII"） 持有公司股份 6,240,029 股，占公司总股本的 5.59%。上述股份为公司首次公开 发行前及上市后资本公积转增股本取得的股份，该部分股份已分别于 2024 年 5 月 22 日、2024 年 6 月 27 日上市流通。 减持计划的主要内容 因自身需要，股东 WI Harpe ...

人民财讯9月29日电，美芯晟(688458)9月29日公告，持股5.59%的股东WIHARPER FUND VII HONG KONG LIMITED拟通过集中竞价、大宗交易方式减持公司股份不超过111.54万股，即不超过公司总股本 的1%。 ...

格隆汇9月29日丨美芯晟(688458.SH)公布，因自身需要，股东 WI Harper Fund VII 拟通过集中竞价、大 宗交易方式减持公司股份不超过111.54万股，即不超过公司总股本的1%，减持期限为自本公告披露之 日起15个交易日后的3个月内进行。减持价格按市场价格确定。 ...